Key terms

About ICLR

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ICLR news

Apr 08 4:31am ET Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neurocrine (NBIX) Apr 05 8:41am ET Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Icon (ICLR) and Teladoc (TDOC) Apr 04 8:20am ET Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA) Apr 04 6:49am ET Icon price target raised to $362 from $345 at Baird Apr 03 4:16pm ET Icon backs FY24 adjusted EPS view $14.50-$15.30, consensus $14.94 Apr 03 4:16pm ET Icon CFO Brendan Brennan to leave company Feb 26 7:40am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Feb 23 8:30am ET Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Icon (ICLR) Feb 23 7:22am ET Icon price target raised to $367 from $357 at Truist Feb 23 6:59am ET Icon price target raised to $345 from $315 at Mizuho Feb 23 6:34am ET Icon price target raised to $345 from $308 at Baird Feb 23 5:47am ET Icon price target raised to $355 from $325 at Barclays Feb 22 3:35pm ET Icon’s Market and Financial Strengths Justify Buy Rating Feb 22 5:40am ET Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR) Feb 22 5:12am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Icon (ICLR) and Crispr Therapeutics AG (CRSP) Feb 21 4:22pm ET Icon announces $500M share repurchase program Feb 21 4:21pm ET Icon affirms 2024 adjusted EPS outlook $14.50-$15.30, consensus $14.91 Jan 24 7:19am ET Icon price target raised to $325 from $280 at Barclays Jan 10 8:30am ET Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Biogen (BIIB) Jan 10 6:51am ET Icon price target raised to $308 from $304 at Baird Jan 10 5:40am ET Analysts Are Bullish on These Healthcare Stocks: Icon (ICLR), Glaukos (GKOS)

No recent news articles are available for ICLR

No recent press releases are available for ICLR

ICLR Financials

1-year income & revenue

Key terms

ICLR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ICLR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms